Article
Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.
Journal of the National Cancer Institute - 2 Oct 2002
Wang Fei, Hansen Rhonda K, Radisky Derek, Yoneda Toshiyuki, Barcellos-Hoff Mary Helen, Petersen Ole W, Turley Eva A, Bissell Mina J
Abstract excerpt
BACKGROUND: We previously used a three-dimensional (3D) reconstituted basement membrane (rBM) assay to demonstrate that tumorigenic HMT-3522 T4-2 human breast cells can be induced to form morphologically normal structures ("reversion") by treatment with inhibitors of beta1 integrin, the epidermal growth factor receptor (EGFR), or mitogen-activated protein kinase (MAPK). We have now used this assay to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
